Matrix Capital Management Company, LP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Matrix Capital Management Company, LP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$63,070,616
-18.8%
11,572,5900.0%0.76%
-16.1%
Q2 2023$77,652,079
-24.0%
11,572,5900.0%0.90%
-35.0%
Q1 2023$102,185,970
+15.6%
11,572,5900.0%1.39%
-17.8%
Q4 2022$88,414,588
+7.3%
11,572,5900.0%1.69%
+7.1%
Q3 2022$82,397,000
-12.0%
11,572,5900.0%1.58%
-25.7%
Q2 2022$93,622,000
-41.7%
11,572,5900.0%2.12%
+10.1%
Q1 2022$160,628,000
-50.5%
11,572,5900.0%1.93%
-46.7%
Q4 2021$324,727,000
-17.4%
11,572,5900.0%3.62%
-19.3%
Q3 2021$393,352,000
-18.4%
11,572,590
-1.9%
4.48%
-15.0%
Q2 2021$482,152,000
-2.7%
11,800,090
-4.1%
5.27%
-8.0%
Q1 2021$495,564,000
-36.1%
12,309,090
-6.1%
5.72%
-31.8%
Q4 2020$775,495,000
+21.6%
13,115,0900.0%8.39%
-1.1%
Q3 2020$637,787,000
-12.8%
13,115,090
-13.2%
8.48%
-25.6%
Q2 2020$731,268,000
+74.2%
15,115,0900.0%11.40%
+6.2%
Q1 2020$419,897,000
-19.0%
15,115,090
-12.8%
10.74%
-2.8%
Q4 2019$518,579,000
-3.2%
17,332,1910.0%11.04%
-16.5%
Q3 2019$535,565,000
-36.0%
17,332,1910.0%13.21%
-14.6%
Q2 2019$837,145,00017,332,19115.47%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders